# Acumen Pharmaceuticals, Inc.: Form 8-K, filed Nov 9, 2023

- Company: [Acumen Pharmaceuticals, Inc.](/companies/abos.md) (CIK 1576885)
- Form: 8-K
- Filed: 2023-11-09
- Accepted by EDGAR: Nov 8, 2023, 17:59 ET
- Period: 2023-11-05
- Accession: 0001576885-23-000056
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1576885/000157688523000056/abos-20231105.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1576885/000157688523000056/

## Items reported

- Item 1.01: Entry into a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1576885/000157688523000056/abos-20231105.htm

Filed Nov 9, 2023.
Source: SEC EDGAR, the filing index for accession 0001576885-23-000056. Last ingested by Listed: Nov 5, 2026, 16:24 ET. No prices; not investment advice.